{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE2", "SARS-CoV-2", "cytokine storm", "myocardial injury", "phytochemical", "platelet", "thrombosis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33981235", "DateRevised": {"Year": "2021", "Month": "05", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "26"}], "Language": ["eng"], "ELocationID": ["658273", "10.3389/fphar.2021.658273"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective.", "Pagination": {"StartPage": "658273", "MedlinePgn": "658273"}, "Abstract": {"AbstractText": ["After gaining entry through ACE2 aided by TMPRSS2, the SARS-CoV-2 causes serious complications of the cardiovascular system leading to myocarditis and other myocardial injuries apart from causing lung, kidney and brain dysfunctions. Here in this review, we are going to divulge the cellular and immunological mechanisms behind the cardiovascular, thrombotic and platelet impairments that are caused in COVID-19. In addition, we also propose the significance of various anti-platelet and anti-thrombotic phytochemicals in the treatment of COVID-19. The virus induces many immune-modulatory cytokines and chemokines which help in the intravascular coagulation and create a pro-thrombotic environment along with pulmonary embolism and thrombocytopenia. Different types of innate and adaptive immune cells and their granular contents regulate the pathophysiology of SARS-CoV-2 induced endothelial and platelet dysfunctions which correlate the involvement of platelets with myocardial injury and intravascular thrombi directly or indirectly. Hence, by exploiting the natural bioactive compounds from medicinal plants and inhibiting the platelet mediated thrombus formation can be beneficial for the treatment of SARS-CoV-2 infection."], "CopyrightInformation": "Copyright \u00a9 2021 Beura, Panigrahi, Yadav and Singh."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, India."}], "LastName": "Beura", "ForeName": "Samir K", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, India."}], "LastName": "Panigrahi", "ForeName": "Abhishek R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, India."}], "LastName": "Yadav", "ForeName": "Pooja", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, India."}], "LastName": "Singh", "ForeName": "Sunil K", "Initials": "SK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Akhmerov A., Marb\u00e1n E. (2020). COVID-19 and the heart. Circ. Res. 126, 1443\u20131455. 10.1161/circresaha.120.317055", "ArticleIdList": ["10.1161/circresaha.120.317055", "PMC7188058", "32252591"]}, {"Citation": "Alhogbani T. (2016). Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann. Saudi Med. 36, 78\u201380. 10.5144/0256-4947.2016.78", "ArticleIdList": ["10.5144/0256-4947.2016.78", "PMC6074274", "26922692"]}, {"Citation": "Arachchillage D. J., Remmington C., Rosenberg A., Xu T., Passariello M., Hall D., et al. (2020). Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID\u201019. Br. J. Haematol. 190, e286\u20138. 10.1111/bjh.16927", "ArticleIdList": ["10.1111/bjh.16927", "PMC7300519", "32516429"]}, {"Citation": "Assinger A. (2014). Platelets and infection - an emerging role of platelets in viral infection. Front. Immunol. 5, 649. 10.3389/fimmu.2014.00649", "ArticleIdList": ["10.3389/fimmu.2014.00649", "PMC4270245", "25566260"]}, {"Citation": "Atri D., Siddiqi H. K., Lang J. P., Nauffal V., Morrow D. A., Bohula E. A. (2020). COVID-19 for the cardiologist. JACC 5, 518\u2013536. 10.1016/j.jacbts.2020.04.002", "ArticleIdList": ["10.1016/j.jacbts.2020.04.002", "PMC7151394", "32292848"]}, {"Citation": "Babaei F., Nassiri\u2010Asl M., Hosseinzadeh H. (2020). Curcumin (a constituent of turmeric): new treatment option against COVID\u201019. Food Sci. Nutr. 8, 5215\u20135227. 10.1002/fsn3.1858", "ArticleIdList": ["10.1002/fsn3.1858", "PMC7590269", "33133525"]}, {"Citation": "Badawi A., Ryoo S. G. (2016). Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int. J. Infect. Dis. 49, 129\u2013133. 10.1016/j.ijid.2016.06.015", "ArticleIdList": ["10.1016/j.ijid.2016.06.015", "PMC7110556", "27352628"]}, {"Citation": "Bansal M. (2020). Cardiovascular disease and COVID-19. Diabetes Metab. Syndr. 14 (3), 247\u2013250. 10.1016/j.dsx.2020.03.013", "ArticleIdList": ["10.1016/j.dsx.2020.03.013", "PMC7102662", "32247212"]}, {"Citation": "Battinelli E. M. (2020). COVID-19 concerns aggregate around platelets. J. Am. Soc. Hematol. 136, 1221\u20131223. 10.1182/blood.2020007805", "ArticleIdList": ["10.1182/blood.2020007805", "PMC7483434", "32957116"]}, {"Citation": "Becker R. C. (2020). COVID-19 update: covid-19-associated coagulopathy. J. Thromb. Thrombolysis 50, 54\u201314. 10.1007/s11239-020-02134-3", "ArticleIdList": ["10.1007/s11239-020-02134-3", "PMC7225095", "32415579"]}, {"Citation": "Benarba B., Pandiella A. (2020). Medicinal plants as sources of active molecules against COVID-19. Front. Pharmacol. 11, 1189. 10.3389/fphar.2020.01189", "ArticleIdList": ["10.3389/fphar.2020.01189", "PMC7427466", "32848790"]}, {"Citation": "Biancatelli R. M. L. C., Berrill M., Catravas J. D., Marik P. E. (2020). Quercetina e vitamina C: una terapia sperimentale e sinergica per la prevenzione e il trattamento della mala: a correlata alla SARS-CoV-2 (COVID-19)."}, {"Citation": "Bikdeli B., Madhavan M. V., Jimenez D., Chuich T., Dreyfus I., Driggin E., et al. (2020). COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J. Am. Coll. Cardiol. 75, 2950\u20132973. 10.1016/j.jacc.2020.04.031", "ArticleIdList": ["10.1016/j.jacc.2020.04.031", "PMC7164881", "32311448"]}, {"Citation": "Bojkova D., Wagner J., Shumliakivska M., Aslan G., Saleem U., Hansen A., et al. (2020). SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc. Res. 116 (14), 2207\u20132215. 10.1093/cvr/cvaa267", "ArticleIdList": ["10.1093/cvr/cvaa267", "PMC7543363", "32966582"]}, {"Citation": "Cavalcanti D. D., Raz E., Shapiro M., Dehkharghani S., Yaghi S., Lillemoe K., et al. (2020). Cerebral venous thrombosis associated with COVID-19. AJNR Am. J. Neuroradiol. 41 (8), 1370\u20131376. 10.3174/ajnr.A6644", "ArticleIdList": ["10.3174/ajnr.A6644", "PMC7658892", "32554424"]}, {"Citation": "Chen C., Chen C., Yan J. T., Zhou N., Zhao J. P., Wang D. W. (2020a). Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi 48, E008. 10.3760/cma.j.cn112148-20200225-00123", "ArticleIdList": ["10.3760/cma.j.cn112148-20200225-00123", "32141280"]}, {"Citation": "Chen C., Li H., Hang W., Wang D. W. (2020b). Cardiac injuries in coronavirus disease 2019 (COVID-19). J. Mol. Cell. Cardiol. 145, 25\u201329. 10.1016/j.yjmcc.2020.06.002", "ArticleIdList": ["10.1016/j.yjmcc.2020.06.002", "PMC7831647", "32526224"]}, {"Citation": "Chojnacka K., Witek-Krowiak A., Skrzypczak D., Mikula K., M\u0142ynarz P. (2020). Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus. J. Funct. Foods 73, 104146. 10.1016/j.jff.2020.104146", "ArticleIdList": ["10.1016/j.jff.2020.104146", "PMC7392194", "32834835"]}, {"Citation": "Clerkin K. J., Fried J. A., Raikhelkar J., Sayer G., Griffin J. M., Masoumi A., et al. (2020). COVID-19 and cardiovascular disease. Circulation 141, 1648\u20131655. 10.1161/circulationaha.120.046941", "ArticleIdList": ["10.1161/circulationaha.120.046941", "32200663"]}, {"Citation": "Colaco S., Chhabria K., Singh N., Bhide A., Singh D., Singh A., et al. (2020). Expression of SARS-CoV-2 receptor ACE2 and the spike protein processing enzymes in developing human embryos. arXiv:2004.04935."}, {"Citation": "Dolhnikoff M., Duarte\u2010Neto A. N., de Almeida Monteiro R. A., Ferraz da Silva L. F., Pierre de Oliveira E., Nascimento Saldiva P. H., et al. (2020). Pathological evidence of pulmonary thrombotic phenomena in severe COVID\u201019. J. Thromb. Haemost. 18(6):1517\u20131519. 10.1111/jth.14844", "ArticleIdList": ["10.1111/jth.14844", "PMC7262093", "32294295"]}, {"Citation": "El Haouari M., Rosado J. A. (2016). Medicinal plants with antiplatelet activity. Phytother. Res. 30, 1059\u20131071. 10.1002/ptr.5619", "ArticleIdList": ["10.1002/ptr.5619", "27062716"]}, {"Citation": "Enmozhi S. K., Raja K., Sebastine I., Joseph J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J. Biomol. Struct. Dyn. 1, 1\u20137. 10.1080/07391102.2020.1760136", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Fei Y., Tang N., Liu H., Cao W. (2020). Coagulation dysfunction. Arch. Pathol. Lab. Med. 144, 1223. 10.5858/arpa.2020-0324-SA", "ArticleIdList": ["10.5858/arpa.2020-0324-SA", "32551814"]}, {"Citation": "Fletcher-Sandersj\u00f6\u00f6 A., Bellander B.-M. (2020). Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb. Res. 194, 36\u201341. 10.1016/j.thromres.2020.06.027", "ArticleIdList": ["10.1016/j.thromres.2020.06.027", "PMC7301826", "32569879"]}, {"Citation": "Fraga-Silva R. A., Costa-Fraga F. P., Mur\u00e7a T. M., Moraes P. L., Martins Lima A., Lautner R. Q., et al. (2013). Angiotensin-converting enzyme 2 activation improves endothelial function. Hypertension 61, 1233\u20131238. 10.1161/hypertensionaha.111.00627", "ArticleIdList": ["10.1161/hypertensionaha.111.00627", "PMC3733257", "23608648"]}, {"Citation": "Fraga-Silva R. A., Sorg B. S., Wankhede M., deDeugd C., Ferreira A. J., Jun Y., et al. (2009). ACE2 activation promotes antithrombotic activity. Mol. Med. 16 (5\u20136), 210\u2013215. 10.2119/molmed.2009.00160", "ArticleIdList": ["10.2119/molmed.2009.00160", "PMC2811560", "20111697"]}, {"Citation": "Gambardella J., Sardu C., Morelli M. B., Messina V., Marfella R., Maggi P., et al. (2020). Abstract 221: exosomal microRNAs drive tromboembolism in covid-19. Circulation 142, A221. 10.1161/circ.142.suppl_4.221", "ArticleIdList": ["10.1161/circ.142.suppl_4.221"]}, {"Citation": "Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., et al. (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368, 779\u2013782. 10.1126/science.abb7498", "ArticleIdList": ["10.1126/science.abb7498", "PMC7164392", "32277040"]}, {"Citation": "Ghildiyal R., Prakash V., Chaudhary V. K., Gupta V., Gabrani R. (2016). \u201cPhytochemicals as antiviral agents: recent updates,\u201d in Plant-derived bioactives. Editor Swamy M. (Singapore: Springer; ). 10.1007/978-981-15-1761-7_122", "ArticleIdList": ["10.1007/978-981-15-1761-7_122"]}, {"Citation": "Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., et al. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5 (7), 811\u2013818. 10.1001/jamacardio.2020.1017", "ArticleIdList": ["10.1001/jamacardio.2020.1017", "PMC7101506", "32219356"]}, {"Citation": "Gupta A. K., Jneid H., Addison D., Ardehali H., Boehme A. K., Borgaonkar S., et al. (2020). Current perspectives on Coronavirus 2019 (COVID\u201019) and cardiovascular disease: a white paper by the JAHA editors. J. Am. Heart Assoc. 9, e017013. 10.1161/jaha.120.017013", "ArticleIdList": ["10.1161/jaha.120.017013", "PMC7429024", "32347144"]}, {"Citation": "Hedrich C. M. (2020). COVID-19 - considerations for the paediatric rheumatologist. Clin. Immunol. 214, 108420. 10.1016/j.clim.2020.108420", "ArticleIdList": ["10.1016/j.clim.2020.108420", "PMC7151358", "32283324"]}, {"Citation": "Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O., P\u00f6hlmann S. (2014). TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol. 88, 1293\u20131307. 10.1128/jvi.02202-13", "ArticleIdList": ["10.1128/jvi.02202-13", "PMC3911672", "24227843"]}, {"Citation": "Hirsch G. E., Nazario Viecili P. R., de Almeida A. S., Nascimento S., Porto F. G., Otero J., et al. (2017). Natural products with antiplatelet action. Cpd 23, 1228\u20131246. 10.2174/1381612823666161123151611", "ArticleIdList": ["10.2174/1381612823666161123151611", "27881059"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Kr\u00fcger N., Mueller M. A., Drosten C., P\u00f6hlmann S. (2020a). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv."}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., et al. (2020b). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8. 10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Hottz E. D., Azevedo-Quintanilha I. G., Palhinha L., Teixeira L., Barreto E. A., P\u00e3o C. R. R., et al. (2020). Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients. Blood 136 (11), 1330\u20131341. 10.1182/blood.2020007252", "ArticleIdList": ["10.1182/blood.2020007252", "PMC7483437", "32678428"]}, {"Citation": "Ibrahim I. M., Abdelmalek D. H., Elshahat M. E., Elfiky A. A. (2020). COVID-19 spike-host cell receptor GRP78 binding site prediction. J. Infect. 80, 554\u2013562. 10.1016/j.jinf.2020.02.026", "ArticleIdList": ["10.1016/j.jinf.2020.02.026", "PMC7102553", "32169481"]}, {"Citation": "Izak M., Bussel J. B. (2014). Management of thrombocytopenia. F1000Prime Rep. 6, 45. 10.12703/P6-45", "ArticleIdList": ["10.12703/P6-45", "PMC4047949", "24991422"]}, {"Citation": "Kim K., Do H. J., Oh T. W., Kim K.-Y., Kim T. H., Ma J. Y., et al. (2019). Antiplatelet and antithrombotic activity of a traditional medicine, hwangryunhaedok-tang. Front. Pharmacol. 9, 1502. 10.3389/fphar.2018.01502", "ArticleIdList": ["10.3389/fphar.2018.01502", "PMC6333754", "30687085"]}, {"Citation": "Kim K., Park K.-I. (2019). A review of antiplatelet activity of traditional medicinal herbs on integrative medicine studies. Evid. Based Complement. Alternat. Med. 2019, 7125162. 10.1155/2019/7125162", "ArticleIdList": ["10.1155/2019/7125162", "PMC6335729", "30719065"]}, {"Citation": "Klatt C., Kr\u00fcger I., Zey S., Krott K.-J., Spelleken M., Gowert N. S., et al. (2018). Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis. J. Clin. Invest. 128, 3906\u20133925. 10.1172/jci92077", "ArticleIdList": ["10.1172/jci92077", "PMC6118585", "29952767"]}, {"Citation": "Ko J.-H., Park G. E., Lee J. Y., Lee J. Y., Cho S. Y., Ha Y. E., et al. (2016). Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J. Infect. 73, 468\u2013475. 10.1016/j.jinf.2016.08.005", "ArticleIdList": ["10.1016/j.jinf.2016.08.005", "PMC7112644", "27519621"]}, {"Citation": "Kochi A. N., Tagliari A. P., Forleo G. B., Fassini G. M., Tondo C. (2020). Cardiac and arrhythmic complications in patients with COVID\u201019. J. Cardiovasc. Electrophysiol. 31 (5), 1003\u20131008. 10.1111/jce.14479", "ArticleIdList": ["10.1111/jce.14479", "PMC7262150", "32270559"]}, {"Citation": "Koupenova M., Freedman J. E. (2020). Platelets and COVID-19: inflammation, hyperactivation and additional questions. Circ. Res. 127 (11), 1419\u20131421. 10.1161/CIRCRESAHA.120.318218", "ArticleIdList": ["10.1161/CIRCRESAHA.120.318218", "PMC7641185", "33151798"]}, {"Citation": "Koupenova-Zamor M., Kehrel B. E., Corkrey H. A., Freedman J. E. (2017). Thrombosis and platelets: an update. Eur. Heart J. 38 (11), 785\u2013791. 10.1093/eurheartj/ehw550", "ArticleIdList": ["10.1093/eurheartj/ehw550", "28039338"]}, {"Citation": "Kuba K., Imai Y., Penninger J. M. (2013). Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circ. J. 77, 301\u2013308. 10.1253/circj.cj-12-1544", "ArticleIdList": ["10.1253/circj.cj-12-1544", "23328447"]}, {"Citation": "Kuba K., Imai Y., Rao S., Jiang C., Penninger J. M. (2006). Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J. Mol. Med. 84, 814\u2013820. 10.1007/s00109-006-0094-9", "ArticleIdList": ["10.1007/s00109-006-0094-9", "PMC7079827", "16988814"]}, {"Citation": "Kumar V., Dhanjal J. K., Bhargava P., Kaul A., Wang J., Zhang H., et al. (2020). Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J. Biomol. Struct. Dyn., 1\u201313. 10.1080/07391102.2020.1775704", "ArticleIdList": ["10.1080/07391102.2020.1775704", "PMC7309304", "32469279"]}, {"Citation": "Kuster G. M., Pfister O., Burkard T., Zhou Q., Twerenbold R., Haaf P., et al. (2020). SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19? Eur. Heart J. 41 (19), 1801\u20131803. 10.1093/eurheartj/ehaa235", "ArticleIdList": ["10.1093/eurheartj/ehaa235", "PMC7184407", "32196087"]}, {"Citation": "Lee W., Ku S.-K., Bae J.-S. (2015). Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin. Arch. Pharm. Res. 38, 893\u2013903. 10.1007/s12272-014-0410-9", "ArticleIdList": ["10.1007/s12272-014-0410-9", "24849036"]}, {"Citation": "Levi M., Thachil J. (2020). Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy-either, neither, or both. Semin. Thromb. Hemost. 46, 781. 10.1055/s-0040-1712156", "ArticleIdList": ["10.1055/s-0040-1712156", "PMC7645819", "32512589"]}, {"Citation": "Li X., Geng M., Peng Y., Meng L., Lu S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 10, 102\u2013108. 10.1016/j.jpha.2020.03.001", "ArticleIdList": ["10.1016/j.jpha.2020.03.001", "PMC7104082", "32282863"]}, {"Citation": "Li Y., Jerkic M., Slutsky A. S., Zhang H. (2020). Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit. Care 24, 1\u20136. 10.1186/s13054-020-03118-8", "ArticleIdList": ["10.1186/s13054-020-03118-8", "PMC7347256", "32646459"]}, {"Citation": "Lin M.-H., Chen M.-C., Chen T.-H., Chang H.-Y., Chou T.-C. (2015). Magnolol ameliorates lipopolysaccharide-induced acute lung injury in rats through PPAR-\u03b3-dependent inhibition of NF-kB activation. Int. Immunopharmacol. 28, 270\u2013278. 10.1016/j.intimp.2015.05.051", "ArticleIdList": ["10.1016/j.intimp.2015.05.051", "26072062"]}, {"Citation": "Lippi G., Plebani M., Henry B. M. (2020). Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta 506, 145\u2013148. 10.1016/j.cca.2020.03.022", "ArticleIdList": ["10.1016/j.cca.2020.03.022", "PMC7102663", "32178975"]}, {"Citation": "Liu P. P., Blet A., Smyth D., Li H. (2020). The science underlying COVID-19. Circulation 142, 68. 10.1161/circulationaha.120.047549", "ArticleIdList": ["10.1161/circulationaha.120.047549", "32293910"]}, {"Citation": "Madeddu P. (2020). Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities. Vasc. Biol. 2 (1), E3\u2013E6. 10.1530/VB-20-0008", "ArticleIdList": ["10.1530/VB-20-0008", "PMC7439917", "32923968"]}, {"Citation": "Magro C., Mulvey J. J., Berlin D., Nuovo G., Salvatore S., Harp J., et al. (2020). Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl. Res. 220 (20), 1\u201313. 10.1016/j.trsl.2020.04.007", "ArticleIdList": ["10.1016/j.trsl.2020.04.007", "PMC7158248", "32299776"]}, {"Citation": "Majnooni M. B., Fakhri S., Shokoohinia Y., Kiyani N., Stage K., Mohammadi P., et al. (2020). Phytochemicals: potential therapeutic interventions against coronavirus-associated lung injury. Front. Pharmacol. 11, 1744. 10.3389/fphar.2020.588467", "ArticleIdList": ["10.3389/fphar.2020.588467", "PMC7919380", "33658931"]}, {"Citation": "Manne B. K., Denorme F., Middleton E. A., Portier I., Rowley J. W., Stubben C., et al. (2020). Platelet gene expression and function in patients with COVID-19. Blood 136, 1317. 10.1182/blood.2020007214", "ArticleIdList": ["10.1182/blood.2020007214", "PMC7483430", "32573711"]}, {"Citation": "McFadyen J. D., Stevens H., Peter K. J. C. (2020). The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications. Circ. Res. 127 (4), 571\u2013587. 10.1161/CIRCRESAHA.120.317447", "ArticleIdList": ["10.1161/CIRCRESAHA.120.317447", "PMC7386875", "32586214"]}, {"Citation": "McGonagle D., O\u2019Donnell J. S., Sharif K., Emery P., Bridgewood C. (2020). Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2 (7), e437\u2013e445. 10.1016/S2665-9913(20)30121-1", "ArticleIdList": ["10.1016/S2665-9913(20)30121-1", "PMC7252093", "32835247"]}, {"Citation": "Mehta P., McAuley D. F., Brown M., Sanchez E., Tattersall R. S., Manson J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034. 10.1016/s0140-6736(20)30628-0", "ArticleIdList": ["10.1016/s0140-6736(20)30628-0", "PMC7270045", "32192578"]}, {"Citation": "Merad M., Martin J. C. (2020). Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355\u2013358. 10.1038/s41577-020-0331-4", "ArticleIdList": ["10.1038/s41577-020-0331-4", "PMC7201395", "32376901"]}, {"Citation": "Meyer D., Sielaff F., Hammami M., B\u00f6ttcher-Friebertsh\u00e4user E., Garten W., Steinmetzer T. (2013). Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. Biochem. J. 452, 331\u2013343. 10.1042/bj20130101", "ArticleIdList": ["10.1042/bj20130101", "23527573"]}, {"Citation": "Mohd Nor N. H., Othman F., Mohd Tohit E. R., Md Noor S. (2016). Medicinal herbals with antiplatelet properties benefit in coronary atherothrombotic diseases. Thrombosis 2016, 5952910. 10.1155/2016/5952910", "ArticleIdList": ["10.1155/2016/5952910", "PMC4808659", "27051529"]}, {"Citation": "Morici N., Bottiroli M., Fumagalli R., Marini C., Cattaneo M. (2020). Role of von Willebrand factor and ADAMTS-13 in the pathogenesis of thrombi in SARS-CoV-2 infection: time to rethink. Thromb. Haemost. 120, 1339. 10.1055/s-0040-1713400", "ArticleIdList": ["10.1055/s-0040-1713400", "32575136"]}, {"Citation": "Mughal A., O\u2019Rourke S. T. (2018). Vascular effects of apelin: mechanisms and therapeutic potential. Pharmacol. Ther. 190, 139\u2013147. 10.1016/j.pharmthera.2018.05.013", "ArticleIdList": ["10.1016/j.pharmthera.2018.05.013", "PMC6165679", "29807055"]}, {"Citation": "Muniyappa R., Gubbi S. (2020). COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am. J. Physiol.-Endocrinol. Metab. 318, E736\u2013E741. 10.1152/ajpendo.00124.2020", "ArticleIdList": ["10.1152/ajpendo.00124.2020", "PMC7191633", "32228322"]}, {"Citation": "Ng K. H. L., Wu A. K. L., Cheng V. C. C., Tang B. S. F., Chan C. Y., Yung C. Y., et al. (2005). Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome. Postgrad. Med. J. 81, e3. 10.1136/pgmj.2004.030049", "ArticleIdList": ["10.1136/pgmj.2004.030049", "PMC1743280", "15937197"]}, {"Citation": "Nishiga M., Wang D. W., Han Y., Lewis D. B., Wu J. C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives, Nat. Rev. Cardiol. 17 (9), 543\u2013558. 10.1038/s41569-020-0413-9", "ArticleIdList": ["10.1038/s41569-020-0413-9", "PMC7370876", "32690910"]}, {"Citation": "Ortega\u2010Paz L., Capodanno D., Montalescot G., Angiolillo D. J. (2020). COVID\u201019 associated thrombosis and coagulopathy: review of the pathophysiology and implications for antithrombotic management. J. Am. Heart Assoc. 10 (3), e019650. 10.1161/JAHA.120.019650", "ArticleIdList": ["10.1161/JAHA.120.019650", "PMC7955431", "33228447"]}, {"Citation": "Oudit G. Y., Crackower M. A., Backx P. H., Penninger J. M. (2003). The role of ACE2 in cardiovascular physiology. Trends Cardiovasc. Med. 13, 93\u2013101. 10.1016/s1050-1738(02)00233-5", "ArticleIdList": ["10.1016/s1050-1738(02)00233-5", "12691672"]}, {"Citation": "Prompetchara E., Ketloy C., Palaga T. (2020). Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 38, 1\u20139. 10.12932/ap-200220-0772", "ArticleIdList": ["10.12932/ap-200220-0772", "32105090"]}, {"Citation": "Pryzdial E. L. G., Lin B. H., Sutherland M. R. (2017). \u201cVirus\u2013platelet associations,\u201d in Platelets in Thrombotic and Non-Thrombotic Disorders: pathophysiology, Pharmacology and Therapeutics: an Update. Editors Gresele P., Kleiman N. S., Lopez J. A., Page C. P. (Cham: Springer International Publishing; ), 1085\u20131102."}, {"Citation": "Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., et al. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71, 762\u2013768. 10.1093/cid/ciaa248", "ArticleIdList": ["10.1093/cid/ciaa248", "PMC7108125", "32161940"]}, {"Citation": "Rabelo L. A., Alenina N., Bader M. (2011). ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens. Res. 34, 154\u2013160. 10.1038/hr.2010.235", "ArticleIdList": ["10.1038/hr.2010.235", "21124322"]}, {"Citation": "Rapkiewicz A. V., Mai X., Carsons S. E., Pittaluga S., Kleiner D. E., Berger J. S., et al. (2020). Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine 24, 100434. 10.1016/j.eclinm.2020.100434", "ArticleIdList": ["10.1016/j.eclinm.2020.100434", "PMC7316051", "32766543"]}, {"Citation": "Rathinavel T., Palanisamy M., Palanisamy S., Subramanian A., Thangaswamy S. (2020). Phytochemical 6-gingerol\u2013a promising drug of choice for COVID-19. Int. J. Adv. Sci. Eng. 6 (4), 1482\u20131489. 10.29294/IJASE.6.4.2020.1482-1489", "ArticleIdList": ["10.29294/IJASE.6.4.2020.1482-1489"]}, {"Citation": "Russell B., Moss C., George G., Santaolalla A., Cope A., Papa S., et al. (2020). Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. ecancer 14, 1022. 10.3332/ecancer.2020.1022", "ArticleIdList": ["10.3332/ecancer.2020.1022", "PMC7105343", "32256705"]}, {"Citation": "Sanders J. M., Monogue M. L., Jodlowski T. Z., Cutrell J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama 323, 1824\u20131836. 10.1001/jama.2020.6019", "ArticleIdList": ["10.1001/jama.2020.6019", "32282022"]}, {"Citation": "Shereen M. A., Khan S., Kazmi A., Bashir N., Siddique R. (2020). COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses. J. Adv. Res. 24, 91\u201398. 10.1016/j.jare.2020.03.005", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "PMC7113610", "32257431"]}, {"Citation": "Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X., et al. (2020). COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 27, 1451\u20131454. 10.1038/s41418-020-0530-3", "ArticleIdList": ["10.1038/s41418-020-0530-3", "PMC7091918", "32205856"]}, {"Citation": "Soni V. K., Mehta A., Ratre Y. K., Tiwari A. K., Amit A., Singh R. P., et al. (2020). Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur. J. Pharmacol. 886, 173551. 10.1016/j.ejphar.2020.173551", "ArticleIdList": ["10.1016/j.ejphar.2020.173551", "PMC7832734", "32931783"]}, {"Citation": "Su H., Yao S., Zhao W., Li M., Liu J., Shang W., et al. (2020). Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro . bioRxiv. 10.2210/pdb6m2n/pdb", "ArticleIdList": ["10.2210/pdb6m2n/pdb"]}, {"Citation": "Sun W., Li Z., Shi Z., Wang B., Gao F., Yang Y., et al. (2014). Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms. Eur. J. Orthop. Surg. Traumatol. 24, 525\u2013529. 10.1007/s00590-013-1223-0", "ArticleIdList": ["10.1007/s00590-013-1223-0", "PMC7087763", "23589033"]}, {"Citation": "Swain S. S., Panda S. K., Luyten W. (2020). Phytochemicals against SARS-CoV as potential drug leads. Biomed. J. S2319\u20134170 (20), 30229\u201330238. 10.1016/j.bj.2020.12.002", "ArticleIdList": ["10.1016/j.bj.2020.12.002", "PMC7726715", "33736953"]}, {"Citation": "Tay M. Z., Poh C. M., R\u00e9nia L., MacAry P. A., Ng L. F. P. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374. 10.1038/s41577-020-0311-8", "ArticleIdList": ["10.1038/s41577-020-0311-8", "PMC7187672", "32346093"]}, {"Citation": "Terpos E., Ntanasis\u2010Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T. N., Politou M., et al. (2020). Hematological findings and complications of COVID\u201019. Am. J. Hematol. 95, 834. 10.1002/ajh.25829", "ArticleIdList": ["10.1002/ajh.25829", "PMC7262337", "32282949"]}, {"Citation": "Thevarajan I., Nguyen T. H. O., Koutsakos M., Druce J., Caly L., van de Sandt C. E., et al. (2020). Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat. Med. 26, 453\u2013455. 10.1038/s41591-020-0819-2", "ArticleIdList": ["10.1038/s41591-020-0819-2", "PMC7095036", "32284614"]}, {"Citation": "Tikellis C., Bernardi S., Burns W. C. (2011). Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 20, 62\u201368. 10.1097/MNH.0b013e328341164a", "ArticleIdList": ["10.1097/MNH.0b013e328341164a", "21099686"]}, {"Citation": "Vinciguerra M., Romiti S., Greco E. (2020). Atherosclerosis as pathogenetic substrate for Sars-Cov2 cytokine storm. J. Clin. Med. 9 (7), 2095. 10.3390/jcm9072095", "ArticleIdList": ["10.3390/jcm9072095", "PMC7408959", "32635302"]}, {"Citation": "Walls A. C., Park Y.-J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e6. 10.1016/j.cell.2020.02.058", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Wang J., Hajizadeh N., Moore E. E., McIntyre R. C., Moore P. K., Veress L. A., et al. (2020). Tissue plasminogen activator (tPA) treatment for COVID\u201019 associated acute respiratory distress syndrome (ARDS): a case series. J. Thromb. Haemost. 18, 1752\u20131755. 10.1111/jth.14828", "ArticleIdList": ["10.1111/jth.14828", "PMC7262152", "32267998"]}, {"Citation": "Xiang-Hua Y., Le-Min W., Ai-Bin L., Zhu G., Riquan L., Xu-You Z., et al. (2010). Severe acute respiratory syndrome and venous thromboembolism in multiple organs. Am. J. Respir. Crit. Care Med. 182, 436\u2013437. 10.1164/ajrccm.182.3.436", "ArticleIdList": ["10.1164/ajrccm.182.3.436", "20675682"]}, {"Citation": "Xiong T.-Y., Redwood S., Prendergast B., Chen M. (2020). Coronaviruses and the cardiovascular system: acute and long-term implications. Eur. Heart J. 41 (19), 1798\u20131800. 10.1093/eurheartj/ehaa231", "ArticleIdList": ["10.1093/eurheartj/ehaa231", "PMC7454513", "32186331"]}, {"Citation": "Xu P., Zhou Q., Xu J. (2020). Mechanism of thrombocytopenia in COVID-19 patients. Ann. Hematol. 99, 1205\u20131208. 10.1007/s00277-020-04019-0", "ArticleIdList": ["10.1007/s00277-020-04019-0", "PMC7156897", "32296910"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448. 10.1126/science.abb2762", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Yang M., Li C. K., Li K., Hon K. L., Ng M. H., Chan P. K., et al. (2004). Hematological findings in SARS patients and possible mechanisms (review). Int. J. Mol. Med. 14, 311\u2013315. 10.3892/ijmm.14.2.311", "ArticleIdList": ["10.3892/ijmm.14.2.311", "15254784"]}, {"Citation": "Yang M., Ng M. H., Li C. K. (2005). Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 10, 101\u2013105. 10.1080/10245330400026170", "ArticleIdList": ["10.1080/10245330400026170", "16019455"]}, {"Citation": "Yang X., Yang Q., Wang Y., Wu Y., Xu J., Yu Y., et al. (2020). Thrombocytopenia and its association with mortality in patients with COVID\u201019. J. Thromb. Haemost. 18, 1469\u20131472. 10.1111/jth.14848", "ArticleIdList": ["10.1111/jth.14848", "PMC9906135", "32302435"]}, {"Citation": "Yin S., Huang M., Li D., Tang N. (2020). Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J. Thromb. Thrombolysis, 1\u20134. 10.1007/s11239-020-02105-8", "ArticleIdList": ["10.1007/s11239-020-02105-8", "PMC7124128", "32246317"]}, {"Citation": "Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., et al. (2020b). Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19. Circ. Res. 127 (11), 1404\u20131418. 10.1161/CIRCRESAHA.120.317703", "ArticleIdList": ["10.1161/CIRCRESAHA.120.317703", "PMC7641188", "32938299"]}, {"Citation": "Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., et al. (2020a). Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ. Res. 127, 1404\u20131418. 10.1161/circresaha.120.317703", "ArticleIdList": ["10.1161/circresaha.120.317703", "PMC7641188", "32938299"]}, {"Citation": "Zhang B. Y., Chen M., Chen X. C., Cao K., You Y., Qian Y. J., et al. (2020). Berberine reduces circulating inflammatory mediators in patients with severe COVID-19. Br. J. Surg. 108 (1), e9\u2013e11. 10.1093/bjs/znaa021", "ArticleIdList": ["10.1093/bjs/znaa021", "PMC7799351", "33640910"]}, {"Citation": "Zhang Y., Xiao M., Zhang S., Xia P., Cao W., Jiang W., et al. (2020). Coagulopathy and antiphospholipid antibodies in patients with covid-19. N. Engl. J. Med. 382, e38. 10.1056/NEJMc2007575", "ArticleIdList": ["10.1056/NEJMc2007575", "PMC7161262", "32268022"]}, {"Citation": "Zheng Y.-Y., Ma Y.-T., Zhang J.-Y., Xie X. (2020). COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 17, 259\u2013260. 10.1038/s41569-020-0360-5", "ArticleIdList": ["10.1038/s41569-020-0360-5", "PMC7095524", "32139904"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "25"}, {"Year": "2021", "Month": "3", "Day": "25"}, {"Year": "2021", "Month": "5", "Day": "13", "Hour": "6", "Minute": "24"}, {"Year": "2021", "Month": "5", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "4", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["33981235", "PMC8107428", "10.3389/fphar.2021.658273", "658273"]}}], "PubmedBookArticle": []}